NewsRx

Search our medical news database

Business Update

Agilent offers licenses for technology to place test targets on PCB signal traces

Published in Medical Patent Law Weekly, November 22nd, 2006

Agilent Technologies, Inc., (A) announced the licensing of Agilent Medalist Bead Probe Technology, a proven methodology for placing solder beads, or "bead probes," directly onto printed circuit board (PCB) signal traces.

This advancement addresses the pressing need for more test accessibility on printed circuit boards at in-circuit test (ICT), especially for dense or high-speed PCB designs.

As PCBs get increasingly smaller, the ability to provide test points for in-circuit test becomes more difficult. In addition, designs with high-speed buses also limit where test targets can be placed on board layouts. Workarounds for these test challenges can be...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook